Connection

IVAN ROSAS to Risk Factors

This is a "connection" page, showing publications IVAN ROSAS has written about Risk Factors.
Connection Strength

0.300
  1. Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis? Eur Respir J. 2016 11; 48(5):1271-1273.
    View in: PubMed
    Score: 0.046
  2. Genetics and Idiopathic Interstitial Pneumonias. Semin Respir Crit Care Med. 2016 06; 37(3):321-30.
    View in: PubMed
    Score: 0.045
  3. Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers. Am J Respir Crit Care Med. 2015 Jun 15; 191(12):1403-12.
    View in: PubMed
    Score: 0.042
  4. Pulmonary Fibrosis Stakeholder Summit: A Joint NHLBI, Three Lakes Foundation, and Pulmonary Fibrosis Foundation Workshop Report. Am J Respir Crit Care Med. 2024 02 15; 209(4):362-373.
    View in: PubMed
    Score: 0.019
  5. Primary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications. Transplantation. 2023 08 01; 107(8):1687-1697.
    View in: PubMed
    Score: 0.018
  6. Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis. Chest. 2020 10; 158(4):1546-1554.
    View in: PubMed
    Score: 0.015
  7. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease. Adv Ther. 2019 11; 36(11):3279-3287.
    View in: PubMed
    Score: 0.014
  8. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study. Arthritis Rheumatol. 2019 09; 71(9):1472-1482.
    View in: PubMed
    Score: 0.014
  9. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients. Ann Thorac Surg. 2018 Feb; 105(2):441-447.
    View in: PubMed
    Score: 0.012
  10. Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study. Lancet Respir Med. 2017 11; 5(11):857-868.
    View in: PubMed
    Score: 0.012
  11. The Presence of Pretransplant HLA Antibodies Does Not Impact the Development of Chronic Lung Allograft Dysfunction or CLAD-Related Death. Transplantation. 2017 09; 101(9):2207-2212.
    View in: PubMed
    Score: 0.012
  12. Development and Progression of Interstitial Lung Abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med. 2016 12 15; 194(12):1514-1522.
    View in: PubMed
    Score: 0.012
  13. Predictors and outcomes of unplanned early rehospitalization in the first year following lung transplantation. Clin Transplant. 2016 09; 30(9):1053-8.
    View in: PubMed
    Score: 0.011
  14. Prevalence and outcome of lung cancer in lung transplant recipients. Respir Med. 2015 Mar; 109(3):427-33.
    View in: PubMed
    Score: 0.010
  15. Interstitial pneumonitis and the risk of chronic allograft rejection in lung transplant recipients. Chest. 2013 May; 143(5):1430-1435.
    View in: PubMed
    Score: 0.009
  16. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol. 2010 Jan; 17(1):48-53.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.